Study on Role of Hematological and Inflammatory Marker in Granulomatous Compared to Non-Granulomatous Lymphadenitis
International Journal of Current Pharmaceutical Review and Research · 30.01.2026 · 18 (01)
DOI: 10.25258/ijcpr.18.1.236 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.01.2026. Verfasst von Preeti Sinha und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
An increase in lymphocytes in the lymph node brought on by a variety of diseases, including TB, and lymphoproliferative disorders can cause lymphadenopathy. A basic hemogram using TLC and DLC, as well as ratios obtained from it such as NLR (Neutrophil Lymphocyte Ratio) and PLR (Platelet Lymphocyte Ratio), can be used to evaluate the rise in inflammatory biomarkers caused by granulomatous lymphadenitis. Aim of this study to establish the role of hematological and inflammatory biomarkers in granulomatous and nongranulomatous lymphadenitis.
Methods
The study was conducted in Department of Pathology, JLNMCH, Bhagalpur, Bihar from February 2025 to July 2025. The study included 150 patients with neck mass taking inclusion and exclusion criteria into account. Cytologically proven cases were categorised into granulomatous and non-granulomatous cases depending on cytological evaluation. Different laboratory parameters like TLC, DLC, ESR, CRP, NLR, and PLR were used to compare granulomatous lymphadenitis to non-granulomatous.
Result
In the studied population there were 92(61.3%) females and 58(38.7%) males but when compared to the non-granulomatous lymphadenitis group, females predominated by 70.7% hematological markers like NLR, PLR, and CRP in the granulomatous lymphadenitis group was significantly higher. The mean Neutrophil was considerably higher among granulomatous lymphadenitis but in non-granulomatous lymphadenitis, the group showed considerably greater mean lymphocytes.
Conclusion
In this area, the most common clinical condition associated with cervical lymphadenopathy is tuberculosis. Women are involved most of the time. The existence of granulomatous and non-granulomatous lymphadenitis can be indicated by hematological and biochemical indicators such as NLR, PLR, and CRP prior to FNAC. Particularly at the primary care level, it will assist the treating physician in considering early case identification methodically and preventing diagnostic delays in cases such as tuberculosis.
Zitieren
APA
Sinha, P., & Sah, M. P. (2026). Study on Role of Hematological and Inflammatory Marker in Granulomatous Compared to Non-Granulomatous Lymphadenitis. International Journal of Current Pharmaceutical Review and Research, 18(01). https://doi.org/10.25258/ijcpr.18.1.236
Vancouver
Sinha P, Sah MP. Study on Role of Hematological and Inflammatory Marker in Granulomatous Compared to Non-Granulomatous Lymphadenitis. International Journal of Current Pharmaceutical Review and Research. 2026;18(01). doi:10.25258/ijcpr.18.1.236
BibTeX
@article{Sinha2026,
author = {Sinha, Preeti and Sah, Mukesh Prasad},
title = {Study on Role of Hematological and Inflammatory Marker in Granulomatous Compared to Non-Granulomatous Lymphadenitis},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {01},
doi = {10.25258/ijcpr.18.1.236}
}
EUVIMED